MTIM
COCH icon

Marathon Trading Investment Management’s Envoy Medical COCH Stock Holding History

Marathon Trading Investment Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-98,665
Closed -$997K – 280
2022
Q4 		$997K Hold
98,665
– – 0.12% 96
2022
Q3 		$970K Hold
98,665
– – 0.09% 107
2022
Q2 		$967K Hold
98,665
– – 0.11% 121
2022
Q1 		$964K Hold
98,665
– – 0.08% 139
2021
Q4 		$962K Hold
98,665
– – 0.08% 125
2021
Q3 		$957K Buy
+98,665
New +$955K 0.07% 159

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Marathon Trading Investment Management's COCH Position: Q1 2023 in Review

Marathon Trading Investment Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 98,665 shares — an estimated $997K sold.

Marathon Trading Investment Management first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $997K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Marathon Trading Investment Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Marathon Trading Investment Management sold 98,665 Envoy Medical shares in Q1 2023, an estimated $997K.
  • Marathon Trading Investment Management first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
  • Marathon Trading Investment Management's Envoy Medical position peaked at $997K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Marathon Trading Investment Management's 13F filing for Q1 2023, filed 12 May 2023.